...
search icon
nnnn-img

Anbio Biotechnology Class A Ordinary Shares Share Price

NNNN
NMQ
$24.2
-$1.03
(-4.08%)
1D
Industry: Biotechnology Sector: Health Care

Anbio Biotechnology Class A Ordinary Shares Analyst Forecast

Anbio Biotechnology Class A Ordinary Shares Share Price Chart

Anbio Biotechnology Class A Ordinary Shares Key Stock Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$1.11B
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
420.5
Volume info-icon
This is the total number of shares traded during the most recent trading day.
130.49K
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
0
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$5.18 L
$55.65 H
$24.2

About Anbio Biotechnology Class A Ordinary Shares, Common Stock

Anbio Biotechnology provides in vitro diagnostics (IVD) products in the European Union, the Asia Pacific, North America, South America, Africa, and internationally. It offers SARS-CoV-2 antigen rapid and SARS-CoV-2/influenza A/B antigen rapid tests; and lateral flow immunoassay, fluorescence immunoassay, loop-mediated isothermal amplification, chemiluminescence immunoassay, and reverse-transcription polymerase chain reaction products. It serves over-the-counter, point-of-care testing, and laboratory markets. The company was incorporated in 2021 and is based in Frankfurt am Main, Germany. more

Industry: BiotechnologySector: Health Care

Anbio Biotechnology Class A Ordinary Shares Stock Returns

Time FrameNNNNSectorS&P500
1-Week Return-5.65%-1.08%-1.38%
1-Month Return-41.13%-0.47%-1.81%
3-Month Return3.82%2.13%1.38%
6-Month Return-50.16%17.04%5.68%
1-Year Return319.41%6.56%11.74%

Anbio Biotechnology Class A Ordinary Shares Financials

Dec '21Dec '22Dec '23Dec '24
Total Revenue4.43M23.54M6.71M8.19M[{"date":"2021-12-31","value":18.81,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":28.51,"profit":true},{"date":"2024-12-31","value":34.76,"profit":true}]
Cost of Revenue1.89M10.98M3.35M2.30M[{"date":"2021-12-31","value":17.18,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":30.52,"profit":true},{"date":"2024-12-31","value":20.94,"profit":true}]
Gross Profit2.54M12.56M3.36M5.89M[{"date":"2021-12-31","value":20.23,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":26.75,"profit":true},{"date":"2024-12-31","value":46.84,"profit":true}]
Gross Margin57.40%53.36%50.07%71.90%[{"date":"2021-12-31","value":79.83,"profit":true},{"date":"2022-12-31","value":74.21,"profit":true},{"date":"2023-12-31","value":69.64,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Operating Expenses86.09K2.37M1.40M3.89M[{"date":"2021-12-31","value":2.21,"profit":true},{"date":"2022-12-31","value":60.88,"profit":true},{"date":"2023-12-31","value":35.99,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Operating Income2.46M10.20M1.96M2.00M[{"date":"2021-12-31","value":24.09,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":19.23,"profit":true},{"date":"2024-12-31","value":19.57,"profit":true}]
Total Non-Operating Income/Expense79.94K(150.16K)458.12K714.99K[{"date":"2021-12-31","value":11.18,"profit":true},{"date":"2022-12-31","value":-21,"profit":false},{"date":"2023-12-31","value":64.07,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Pre-Tax Income2.54M10.01M2.25M2.37M[{"date":"2021-12-31","value":25.33,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":22.51,"profit":true},{"date":"2024-12-31","value":23.7,"profit":true}]
Income Taxes----[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Income After Taxes----[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Income From Continuous Operations2.54M10.01M2.25M2.37M[{"date":"2021-12-31","value":25.33,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":22.51,"profit":true},{"date":"2024-12-31","value":23.7,"profit":true}]
Income From Discontinued Operations----[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Net Income2.54M10.01M2.25M2.37M[{"date":"2021-12-31","value":25.33,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":22.51,"profit":true},{"date":"2024-12-31","value":23.7,"profit":true}]
EPS (Diluted)----[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]

Anbio Biotechnology Class A Ordinary Shares Ratios

Anbio Biotechnology Class A Ordinary Shares Liquidity Ratios

These ratios help you determine the liquidity of the company. Higher is better.

NNNN
Cash Ratio 102.41
Current Ratio 211.10

Anbio Biotechnology Class A Ordinary Shares Asset Efficiency Ratios

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

NNNN
ROA (LTM) 4.73%
ROE (LTM) 11.20%

Anbio Biotechnology Class A Ordinary Shares Liability Ratios

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

NNNN
Debt Ratio Lower is generally better. Negative is bad. 0.00
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 1.00

Anbio Biotechnology Class A Ordinary Shares Valuation Ratios

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

NNNN
Trailing PE 420.50
Forward PE NM
P/S (TTM) 160.02
P/B 40.20
Price/FCF 690
EV/R 158.08
EV/Ebitda 510.77

FAQs

What is Anbio Biotechnology Class A Ordinary Shares share price today?

Anbio Biotechnology Class A Ordinary Shares (NNNN) share price today is $24.2

Can Indians buy Anbio Biotechnology Class A Ordinary Shares shares?

Yes, Indians can buy shares of Anbio Biotechnology Class A Ordinary Shares (NNNN) on Vested. To buy

from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in NNNN stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Anbio Biotechnology Class A Ordinary Shares be purchased?

Yes, you can purchase fractional shares of Anbio Biotechnology Class A Ordinary Shares (NNNN) via the Vested app. You can start investing in Anbio Biotechnology Class A Ordinary Shares (NNNN) with a minimum investment of $1.

How to invest in Anbio Biotechnology Class A Ordinary Shares shares from India?

You can invest in shares of Anbio Biotechnology Class A Ordinary Shares (NNNN) via Vested in three simple steps:

  • Click on Sign Up or Invest in NNNN stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Anbio Biotechnology Class A Ordinary Shares shares
What is Anbio Biotechnology Class A Ordinary Shares 52-week high and low stock price?

The 52-week high price of Anbio Biotechnology Class A Ordinary Shares (NNNN) is $55.65. The 52-week low price of Anbio Biotechnology Class A Ordinary Shares (NNNN) is $5.18.

What is Anbio Biotechnology Class A Ordinary Shares price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of Anbio Biotechnology Class A Ordinary Shares (NNNN) is 420.5

What is Anbio Biotechnology Class A Ordinary Shares price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Anbio Biotechnology Class A Ordinary Shares (NNNN) is 40.20

What is Anbio Biotechnology Class A Ordinary Shares dividend yield?

The dividend yield of Anbio Biotechnology Class A Ordinary Shares (NNNN) is 0.00%

What is the Market Cap of Anbio Biotechnology Class A Ordinary Shares?

The market capitalization of Anbio Biotechnology Class A Ordinary Shares (NNNN) is $1.11B

What is Anbio Biotechnology Class A Ordinary Shares's stock symbol?

The stock symbol (or ticker) of Anbio Biotechnology Class A Ordinary Shares is NNNN

How Can Investors Use Anbio Biotechnology Class A Ordinary Shares Share Price Data for Long-Term Investment Decisions?

Consider the share price of Anbio Biotechnology Class A Ordinary Shares as a long-term story and not a daily point list. The price represents a movement of the stock in both good and bad times when looked at over many years. This assists the investors to know whether Anbio Biotechnology Class A Ordinary Shares has succeeded to expand steadily and overcome market declines. With this price movement observed and the way the business is progressing, it is easier to make a decision whether the stock is worth having in the long term or not.

How does USD - INR currency movement impact returns from Anbio Biotechnology Class A Ordinary Shares shares for Indian investors?

When investing in Anbio Biotechnology Class A Ordinary Shares shares, you are not based in India then your investment is not just based on the stock price. It is also determined by the currency movement of the dollar in relation to the rupee. When you have an appreciation of the Anbio Biotechnology Class A Ordinary Shares stock and the dollar appreciation is also the same, you gain more in terms of rupees. When the rupee appreciated, it will lower your profits. This currency flow is a silent cause of great contribution to your ultimate returns over many years.

How should investors compare Anbio Biotechnology Class A Ordinary Shares share price with other stocks in the same sector?

Rather than merely checking the share price of Anbio Biotechnology Class A Ordinary Shares and comparing it with that of other stocks in the same sector, one can check how robust the business is. Investors tend to compare such aspects as profits, cash generation, and the stability of the revenues of the company. This means that Anbio Biotechnology Class A Ordinary Shares stock in most cases does not react in the same manner as other companies in the sector due to its brand and services revenue.

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top